Prestigious Prize Honors Pioneering Immune System Discoveries

The Nobel Prize in Physiology or Medicine has been granted for revolutionary findings that clarify how the immune system attacks harmful infections while protecting the healthy tissues.

Three esteemed scientists—from Japan Prof. Sakaguchi and US experts Dr. Brunkow and Fred Ramsdell—received this honor.

The research identified specialized "sentinels" within the immune system that eliminate rogue defense cells capable of harming the body.

The discoveries are now paving the way for innovative treatments for immune disorders and cancer.

The winners will share a prize fund valued at 11m Swedish kronor.

Decisive Discoveries

"Their research has been decisive for understanding how the body's defenses operates and the reason we don't all suffer from serious autoimmune diseases," commented the head of the award panel.

This trio's studies explain a core question: How does the defense system protect us from numerous invaders while leaving our healthy cells unharmed?

Our body's protection system employs immune cells that scan for indicators of disease, even pathogens and bacteria it has never encountered.

These cells utilize detectors—known as recognition units—that are produced randomly in a vast number of variations.

This provides the immune system the capacity to fight a wide array of threats, but the unpredictability of the mechanism inevitably produces immune cells that can attack the host.

Protectors of the Immune System

Scientists previously understood that some of these problematic defense cells were eliminated in the thymus—where immune cells mature.

The latest Nobel Prize recognizes the identification of T-reg cells—described as the immune system's "security guards"—which travel through the system to neutralize any defenders that assault the body's own tissues.

It is known that this mechanism malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

A Nobel panel added, "These discoveries have established a new field of research and accelerated the development of innovative treatments, for example for cancer and autoimmune diseases."

Regarding cancer, regulatory T-cells block the body from fighting the growth, so research are focused on reducing their numbers.

For autoimmune diseases, experiments are testing increasing T-reg cells so the organism is not under attack. A comparable method could also be useful in minimizing the risks of transplanted organ failure.

Innovative Experiments

Professor Shimon Sakaguchi, from Osaka University, conducted tests on mice that had their immune gland removed, causing self-attack conditions.

He demonstrated that injecting immune cells from other animals could stop the disease—implying there was a mechanism for preventing defenders from attacking the host.

Dr. Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, now at a biotech firm in San Francisco, were investigating an inherited immune disorder in rodents and humans that resulted in the identification of a gene vital for how regulatory T-cells operate.

"Their pioneering research has uncovered how the immune system is kept in check by T-reg cells, preventing it from mistakenly attacking the healthy cells," commented a prominent physiology specialist.

"This research is a remarkable example of how basic biological study can have broad consequences for human health."